Joint Replacement Patients with Diabetes Greatly Benefit from Controlled Glucose
Posted on: Wednesday, 1 July 2009, 06:00 CDT
New study finds controlled glucose levels help decrease chance for complications
"We found that controlled glucose levels really do make a difference for the patient," said study co-author
The study found that patients with uncontrolled glucose levels were:
- More than 3 times as likely to experience a stroke or death after joint replacement surgery; and
- About twice as likely to experience post-operative bleeding and infection.
Dr. Marchant and his colleagues reviewed data from a national healthcare database looking at more than one million patients who had total joint replacement surgery from 1988 to 2005. They compared surgical outcomes in patients with uncontrolled glucose levels to those who had controlled glucose levels and those patients who did not have diabetes.
"It did not matter if the patient had Type I or Type II diabetes," explains Dr. Marchant. "Regardless of diabetes type, we found that patients had fewer complications after surgery if their glucose level was controlled before, during and after surgery."
Diabetic patients with uncontrolled glucose were more likely to experience surgical complications, infection, blood transfusions and longer hospitals stays.
"The factors necessary for diabetic patients to be considered 'under control' are different for each individual patient, therefore diabetic patients should have good relationships with their medical doctors," said Dr. Marchant.
Study authors say that according to the American Diabetes Association, disease control is determined for each patient based on a series of laboratory blood tests and an assessment of diabetes-related illnesses. Approximately 8 percent of patients undergoing total hip and knee replacement in
"It is crucial that patients have glucose levels well managed before, during and after surgery because it reduces the potential of having a complication," notes Dr. Marchant. "This is the responsibility of both the patient and the surgeon, and it should be a priority."
Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. Commercial entities (Zimmer and DePuy) paid or directed in any one year, or agreed to pay or direct, benefits in excess of
SOURCE American Academy of Orthopaedic Surgeons
Source: PR Newswire
Related Articles
- Stanford University and Veterans Affairs Researchers Demonstrate Significant Glucose Reduction in Study of CVAC Process for Insulin Resistance and Diabetes
- World's Largest Trial of Intensive Glucose Control in Type 2 Diabetes Finds Significant Reduction in Serious Complications -- 21% Reduced Kidney Disease Risk
- Echo Therapeutics Announces Positive Results From Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
- Freedom Meditech Executes License for Non-Invasive Glucose Monitoring Technology for Diabetes
- Weight Loss Surgery Helps Prevent Diabetes
- Seabird Droppings Raising Arctic Chemical Levels: Study
- Changes in Features of the Metabolic Syndrome and Incident Impaired Glucose Regulation or Type 2 Diabetes in a Chinese Population
- The High-Fat Diet-Fed Mouse: A Model for Studying Mechanisms and Treatment of Impaired Glucose Tolerance and Type 2 Diabetes
- Case Study: Diabetic Ketoacidosis in Type 2 Diabetes: "Look Under the Sheets"
- Study: Diabetes Raises Other Health Risks
User Comments (0)

RSS Feeds